Whopping $562 Million Sale at Warner Chilcott

The pharmaceuticals firm saw two 10% owners and the CFO sell large blocks.

Two 10% owners and executives including the chief financial officer at drug maker Warner Chilcott sold a whopping total of $561,529,443 in stock on Sept. 11 in the wake of a special dividend, a secondary offering and multiyear low stock price. They were joined by big institutional holders who slashed their stakes by more than half.